• 4 days Quantum Computing Is The Newest Megatrend In Silicon Valley
  • 5 days How To Invest In The Cybersecurity Boom
  • 7 days Investors Are Patient With Unprofitable Giants
  • 9 days Wells Fargo Back In The Scandal Spotlight Once Again
  • 11 days 5 Stocks To Keep A Close Eye On This Year
  • 12 days As Auto Giants Flail, Look To Chip Stocks For Gains
  • 13 days Central America Is Ready For The Bitcoin Hustle
  • 15 days China’s Video Game Restrictions Unlikely To Slow Down Booming Industry
  • 16 days Top Performing Stocks As Inflation Fears Grow
  • 17 days US Airline Stocks Take A Beating On New EU Restrictions
  • 18 days This IPO Could Open Sustainable Fashion Floodgates
  • 19 days Crypto Crime Nets Another $2B Fraudster
  • 21 days This Week’s Hottest Meme Stocks
  • 22 days Why World Markets Should Be Watching Germany Closely
  • 24 days Could ‘Cultured’ Meat Rival The Plant-Based Megatrend?
  • 26 days ‘Easy Money’: Crypto Is Still Attracting Newbie Investors
  • 28 days Foreign Syndicates May Have Stolen Up To $400B In COVID Benefits
  • 29 days Gold Jumps Above $1800 Ahead Of Jackson Hole Summit
  • 29 days International Banks Blacklist Afghanistan Following Taliban Takeover
  • 31 days China’s Tycoons Are Getting A Serious Reality Check
Bezos Is Heading To Space This Sunday

Bezos Is Heading To Space This Sunday

The ongoing space race has…

Space Is About To Get Its First Hotel

Space Is About To Get Its First Hotel

By 2027, we’ll have our…

  1. Home
  2. News
  3. Breaking News

FDA Turns Its Back On “The Fountain Of Youth”

Blood

Legend is that Keith Richards of Rolling Stones went regularly to Swiss medical clinics to get his blood replaced in a bid to beat his lifestyle. It was just a legend, and never proven. But fast forward a couple of decades and we have Baby Boomers looking in greater numbers for that “fountain of youth”.

They think they found it, but the Federal Drug Administration (FDA) says “no”.

What the FDA is saying “no” to is this: An increasing number of companies offering injections of blood from younger people to combat the signs of aging. Last week, the FDA issued a statement expressing concern that “some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies.”

“Such treatments have no proven clinical benefits for the uses for which these clinics are advertising them, and are potentially harmful,” the FDA said.

The agency also said that some companies are selling plasma transfusions as supposed "treatments" for conditions like normal aging, memory loss, dementia, Parkinson’s disease, multiple sclerosis…

Even though the statement didn't call out any companies by name, it was clearly targeting the best-known among these—California-based Ambrosia Medical, which since 2017, Ambrosia ‘anti-aging” treatment for $8,000 for one liter of blood and $12,000 for two Related: Is Bitcoin Heading For A Bull Run?

Following the FDA’s warning, Ambrosia’s on Tuesday changed its website to state that it had “ceased patient treatments”.  

While the company says that most participants “see improvements” from the one-time infusion of a two-liter bagful of plasma, scientists and clinicians call it a scam.

But an opportunity is knocking hard on this vampire quest—and some won’t be able to resist.

Even the big dogs are toying with the idea. Google’s parent company, Alphabet, has invested heavily in its secretive anti-aging spinout, called Calico.

Celularity, a biotech giant Celgene spinoff, raised $250 million last year to try to use postpartum placentas to delay the aging process.

And then there is a company called Elysium Health, which has talked Nobel Prize winners into selling a $50-per-month supplement aimed at promoting longevity.

Related: Major Investment Banks Turn Bullish On Copper

Last year, one Florida-based former mortician and doctor announced the launch of a clinical trial giving participants blood infusions from young donors for $285,000 “enrollment” fee.

A couple of years ago, some U.S. citizens were reportedly hospitalized after traveling to Germany as “medical tourists” for a controversial treatment involving injections with sheep cells. They allegedly visited Germany twice a year for this type of treatment—involving fetal cells from sheep-which is not permitted in the U.S. The treatment is said to be used for everything from impotence to migraines, as well as anti-aging.

But from the FDA’s perspective, this is the 21st Centuries snake oil—and none of it has been proven.

By Michael Kern for Safehaven.com

More Top Reads From Safehaven.com:

Back to homepage

Leave a comment
  • Panskeptic on February 28 2019 said:
    You are flat-out wrong to lump Elysium Basis in with the other treatments. MIT is a respected scientific institution, and somehow I don't see a bunch of Nobel Prize-winners as gullible innocents.

    Go back and do some more research. This was just plain sloppy reporting.

Leave a comment